Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Study Expands Bone Biology Knowledge

May 9, 2011 8:50 am | News | Comments

Acceleron Pharma, Inc. announced preclinical data highlighting the significant anabolic bone effects in normal and osteopenic mice of RAP-661.


Capturing More in Microscopy Images

May 9, 2011 8:49 am | by Mike May, PhD, Contributing Editor | Articles | Comments

Advanced microscopic cameras use sophisticated sensors to capture images. New developments in sensors are bringing more features into view.


Using Bead-Based Multiplexing Immunoassays to Explore Cellular Response to Drugs

May 9, 2011 8:36 am | by Brett Houser, Bio-Plex Product Manager; Bio-Rad Laboratories,Hercules, Calif. | Articles | Comments

Multiplex bead-based immunoassays, such as Luminex xMAP technology, allow the simultaneous measurement of multiple analytes using a library of antibodies coupled to color-coded beads.


Spectroscopic Data System

May 9, 2011 8:30 am | Product Releases | Comments

Symbion Systems, Inc. released the Symbion-DX, Version 2.5, which includes expanded database functionality, instrument control, spectroscopic data processing, and methods development capabilities.


Increasing Immunoassay Specificity with Novel Plate Formats

May 9, 2011 8:30 am | by Thomas Andersen, MSc, Sr. Technical Adviser; Thermo Fisher Scientific, Roskilde, Denmark | Articles | Comments

Immunoassays are based on the ability of an antibody to bind with high specificity to a specific antigen molecule, producing a measurable signal that can be used to determine quantitative information of the antigen concentration.


Multiplex Chemiluminescent ELISA for the Detection of Interferons and Related Cytokines

May 9, 2011 8:23 am | by Thomas. B. Lavoie, PhD, Director of Product Development; William Clark, PhD, Vice President of Science and Strategic Alliance; Yognandan Pandya, Quality Manager; PBL InterferonSource, Piscataway, NJ | Articles | Comments

Multiplex technology has become a powerful tool for examining analytes in a variety of biological samples. The advantages of this approach include time, sample, and cost savings relative to singleplex analysis of samples.


Researchers Find Temperature-Sensing Protein

May 9, 2011 8:11 am | News | Comments

Researchers at The Scripps Research Institute found a temperature-sensing protein that allows calcium to pour in and activate an immune response when tripped.


Data Delivery of INDs

May 9, 2011 8:11 am | by Scott Weiss, PhD, Director of Product Strategy; ID Business Solutions Ltd, Bridgewater, N.J. | Articles | Comments

At a time of unprecedented change within the pharmaceutical industry, improved insight into the process and the efficient progression of preclinical discoveries into clinical development projects is critical.


Zombie Ants Have Fungus on Brain

May 9, 2011 8:08 am | News | Comments

New research revealed how infection by a parasitic fungus dramatically changes the behavior of tropical of carpenter ants, causing them to become zombie-like and to die...


Biomarker Researchers Seek Qualified Successes

May 9, 2011 7:36 am | by Alan Dove, Contributing Editor | Articles | Comments

The barriers between the biomarker lab and the clinic are manifold, but validation and qualification are clearly the biggest. New guidelines, tools, and techniques are helping scientists mine a mountain of potential biomarkers for a few precious gems.


J & J Files New Concerta Lawsuit Against Impax Labs

May 9, 2011 5:49 am | News | Comments

Impax Laboratories Inc. received a second patent lawsuit from Johnson & Johnson's Alza Corp. division related to Impax's proposed generic version of drug Concerta, which treats the attention deficit hyperactivity disorder.


Alkermes, Elan Drug Technologies to Merge

May 9, 2011 5:45 am | News | Comments

Alkermes, Inc and Elan Corporation announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies (EDT), in a cash and stock transaction currently valued at approximately $960 million.


French Drugmaker Shortens Name to Sanofi

May 9, 2011 5:34 am | News | Comments

French drugmaker Sanofi-Aventis SA shortened its name to Sanofi, a move approved by shareholders at the company's annual meeting in Paris.


The Heart of Dosing Safety

May 6, 2011 1:11 pm | by Alan Copa, PharmD, President, Cetero Research, Fargo, N.D. | Articles | Comments

Over the last decade, cardiac safety concerns have become the leading reason that drugs are pulled from the market. As a result, thorough QT studies are more important than ever.


The Softer Side of Genomics

May 6, 2011 12:44 pm | by Mike May, PhD; Contributing Editor | Articles | Comments

Today’s data-management and computational tools let researchers dig deeper into genes.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.